Differentiated Thyroid Cancer
📧 Sign up to get email alerts when something new happens for Differentiated Thyroid Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-01-26Clinical Trial Update: A Trial of Lenvatinib (E7080) in Radioiodine (131 I)-Refractory Differentiated Thyroid Cancer in China [Phase 3]
Phase 3 trial assessing lenvatinib (E7080) in radioiodine-refractory differentiated thyroid cancer conducted in China has completed.
-
CLINICAL_TRIALS trial_result · 2022-01-20Clinical Trial Update: Study of Apatinib in Patients With Differentiated Thyroid Cancer [Phase 2]
Phase 2 clinical trial update of apatinib in differentiated thyroid cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-12-13Clinical Trial Update: A Phase 3 Study of Donafenib in Patients With Radioiodine-refractory Differentiated Thyroid Cancer [Phase 3]
Phase 3 study of donafenib in radioiodine-refractory differentiated thyroid cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2021-10-26Clinical Trial Update: Study of Everolimus and Sorafenib in Patients With Advanced Thyroid Cancer Who Progressed on Sorafenib Alone [Phase 2]
Phase 2 clinical trial evaluating the combination of everolimus and sorafenib in differentiated thyroid cancer patients who progressed on so…
-
CLINICAL_TRIALS trial_result · 2021-10-18Clinical Trial Update: 99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Osteoporosis [NA]
Clinical trial update on 99Tc-MDP in postmenopausal women with differentiated thyroid cancer and osteoporosis; trial completed with results …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-10-15Clinical Trial Update: A Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-Refractory Differentiated Thyroid Carcinoma (DTC) in the First-line Setting [Phase 2]
Phase II trial investigating cabozantinib as first-line treatment for radioiodine-refractory differentiated thyroid carcinoma (DTC).
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer [Phase 2]
Phase 2 adaptive TKI therapy trial in thyroid cancer was terminated; results posted previously.
-
CLINICAL_TRIALS trial_result · 2021-01-11Clinical Trial Update: A Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 Milligram (mg) Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile [Phase 2]
Phase 2 trial evaluating whether starting lenvatinib at 18 mg daily offers comparable efficacy to 24 mg with a better safety profile in iodi…
-
CLINICAL_TRIALS trial_result · 2020-09-17Clinical Trial Update: Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma [Phase 1, Phase 2]
Phase 1/2 trial of lenvatinib in pediatric/adolescent and young adult patients with refractory or relapsed solid malignancies and osteosarco…
-
CLINICAL_TRIALS trial_result · 2020-07-31Clinical Trial Update: Nintedanib(BIBF1120) in Thyroid Cancer [Phase 2]
Phase 2 trial of nintedanib (BIBF1120) in thyroid cancer (medullary and differentiated thyroid cancer) has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-27Clinical Trial Update: Study of Neoadjuvant Regimen for Radioactive Iodine Treatment of Metastatic and Advanced Differentiated Thyroid Cancers [Phase 2]
Phase 2 trial evaluating a neoadjuvant regimen for radioactive iodine treatment in metastatic and advanced differentiated thyroid cancers; s…
-
CLINICAL_TRIALS trial_result · 2019-11-18Clinical Trial Update: Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer [Phase 2]
Phase II trial of Sorafenib (Nexavar) in advanced thyroid cancers completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-08-01Clinical Trial Update: Evaluating the Safety and Efficacy of Oral Lenvatinib in Medullary and Iodine-131 Refractory, Unresectable Differentiated Thyroid Cancers, Stratified by Histology [Phase 2]
Phase 2 trial evaluating safety and efficacy of oral lenvatinib in medullary and iodine-131 refractory, unresectable differentiated thyroid …
-
CLINICAL_TRIALS trial_result · 2019-06-11Clinical Trial Update: Efficacy of Radium 223 in Radioactive Iodine Refractory Bone Metastases From Differentiated Thyroid Cancer [Phase 2]
Phase 2 clinical trial update evaluating efficacy of Radium 223 in radioactive iodine-refractory bone metastases from differentiated thyroid…
-
CLINICAL_TRIALS trial_result · 2019-05-21Clinical Trial Update: Study of Anlotinib in Patients With Differentiated Thyroid Cancer(ALTER01032) [Phase 2, Phase 3]
Clinical trial update for Anlotinib in differentiated thyroid cancer across Phase 2 and Phase 3 stages.
-
CLINICAL_TRIALS trial_result · 2019-04-22Clinical Trial Update: Comparing Complete Remission After Treatment With Selumetinib/Placebo in Patient With Differentiated Thyroid Cancer [Phase 3]
Phase 3 trial comparing selumetinib to placebo in differentiated thyroid cancer was terminated; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-03-01Clinical Trial Update: Phase 2 Trial of Donafenib in 131I-Refractory Differentiated Thyroid Cancer [Phase 2]
A completed Phase 2 trial evaluating donafenib in iodine-131 refractory differentiated thyroid cancer.
-
CLINICAL_TRIALS trial_result · 2018-12-21Clinical Trial Update: CUDC-907 Treatment in People With Metastatic and Locally Advanced Thyroid Cancer [Phase 2]
Phase 2 trial update for CUDC-907 in metastatic and locally advanced thyroid cancer; study terminated with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-10-23Clinical Trial Update: Safety and Efficacy of VB-111 in Subjects With Advanced Differentiated Thyroid Cancer [Phase 2]
Phase 2 clinical trial update evaluating safety and efficacy of VB-111 in advanced differentiated thyroid cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-04-18Clinical Trial Update: Sutent Adjunctive Treatment of Differentiated Thyroid Cancer [Phase 2]
Phase 2 trial evaluating Sutent as adjunctive therapy for differentiated thyroid cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-06-19Clinical Trial Update: PET-guided External Beam Radiotherapy in Differentiated Thyroid Cancer
A completed clinical trial evaluating PET-guided external beam radiotherapy for differentiated thyroid cancer has been reported.
-
CLINICAL_TRIALS trial_result · 2017-03-13Clinical Trial Update: Evaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid Cancer [Phase 3]
A Phase 3 clinical trial evaluated Vandetanib for efficacy and safety in patients with Differentiated thyroid cancer and has completed with …
-
CLINICAL_TRIALS trial_result · 2016-12-12Clinical Trial Update: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Trial of Lenvatinib (E7080) in 131I-Refractory Differentiated Thyroid Cancer (DTC) [Phase 3]
Phase 3 clinical trial of lenvatinib in iodine-refractory differentiated thyroid cancer completed with posted results in 2016.
-
CLINICAL_TRIALS trial_result · 2015-03-18Clinical Trial Update: A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen. [Phase 3]
Phase 3 follow-up trial in differentiated thyroid cancer patients who previously participated in a study comparing standard thyroid remnant …
-
CLINICAL_TRIALS trial_result · 2014-02-11Clinical Trial Update: Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid Cancer [Phase 2]
Phase 2 trial of celecoxib for progressive metastatic differentiated thyroid cancer has completed.